ProShares UltraShort NASDAQ Biotechnology
4 hedge funds and large institutions have $1.83M invested in ProShares UltraShort NASDAQ Biotechnology in 2013 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
4
Holders Change
+4
Holders Change %
–
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CS
1
Credit Suisse
Zurich,
Switzerland
|
$1.31M |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$269K |
| 3 |
3
Jane Street
New York
|
$214K |
| 4 |
U
4
UBS
Zurich,
Switzerland
|
$37K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CS
1
Credit Suisse
Zurich,
Switzerland
| $1.31M | 34,468 | +34,468 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $269K | 7,013 | +7,013 | New |
|
|
3
Jane Street
New York
| $214K | 5,659 | +5,659 | New |
|
|
U
4
UBS
Zurich,
Switzerland
| $37K | 986 | +986 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | – | – | – |
|